Skip to content
OpenCapital
Get started

LONA LONA EBIT

EBIT at other companies

Arvinas logo
ArvinasARVN
-$63.8M-189%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$57.99M-66.3%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
-$34.87M-20.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$30.93M+27.9%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$187.91M-427%
Eli Lilly logo
Eli LillyLLY
——

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M—

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0×0.0×
Current ratio10.4×+3.1×

Where this comes from

Calculated from LONA’s reported figures.

−$17.2Moperating income=-$17.21M

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's EBIT?
LONA (LONA) reported EBIT of -$17.21M in Q1 2026.
How has LONA's EBIT changed year-over-year?
LONA's EBIT decreased by 80.5% year-over-year, from -$9.54M to -$17.21M.
What is the long-term trend for LONA's EBIT?
Over 4 years (2021 to 2025), LONA's EBIT has grown at a 12.4% compound annual growth rate (CAGR), from -$64.02M to -$102.27M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.